Evidence map›Paper›PMID 23295261›Full record

ArticleNature structural & molecular biology2013

Chromatin proteins captured by ChIP-mass spectrometry are linked to dosage compensation in Drosophila.

Charlotte I Wang, Artyom A Alekseyenko, Gary LeRoy, Andrew E H Elia, Andrey A Gorchakov, Laura-Mae P Britton, Stephen J Elledge, Peter V Kharchenko, Benjamin A Garcia, Mitzi I Kuroda

Open access · greenAbstract read
In one paragraph

Article in Nature structural & molecular biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 125 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Set2 and H3K36 regulate thebioRxiv : the preprint server for biology · 2024
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Variant Polycomb complexes inScience advances · 2022
    Article
  18. Article
  19. Article
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Charlotte I WangDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Artyom A Alekseyenko
Gary LeRoy
Andrew E H Elia
Andrey A Gorchakov
Laura-Mae P Britton
Stephen J Elledge
Peter V Kharchenko
Benjamin A Garcia
Mitzi I Kuroda
Brigham and Women's Hospital · USHarvard University · USPrinceton University · USCenter for Systems Biology · US

Funding

Drosophila Transgenic RNAi Resource ProjectR01GM084947 · NIGMS · HARVARD MEDICAL SCHOOL · PI PERRIMON, NORBERT · 2008 to 2019
$9.8M
Molecular Genetics of Dosage Compensation in DrosophilaR37GM045744 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI KURODA, MITZI I · 2004 to 2013
$3.7M
Genetics of Cell Cycle &DNA Damage Regulation in YeastR37GM044664 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI ELLEDGE, STEPHEN J · 2003 to 2012
$3.5M
Comprehensive analysis of epigenetic regulators in their native chromatin contextR01GM101958 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI KURODA, MITZI I · 2012 to 2018
$2.4M
Novel Methodology for Quantitative High-throughput Cancer EpigeneticsDP2OD007447 · OD · UNIVERSITY OF PENNSYLVANIA · PI GARCIA, BENJAMIN A · 2010 to 2010
$2.4M
MOLECULAR GENETICS OF DOSAGE COMPENSATION IN DROSOPHILAR01GM045744 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI KURODA, MITZI I · 1991 to 2017
$2.3M
GENETICS OF CELL CYCLE &DNA DAMAGE REGULATION IN YEASTR01GM044664 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI ELLEDGE, STEPHEN J · 1990 to 2016
$2.0M
Age-associated chromatin changes in hematopoiesisK25AG037596 · NIA · HARVARD MEDICAL SCHOOL · PI KHARCHENKO, PETER V · 2010 to 2014
$749k
Howard Hughes Medical InstituteNIA NIH HHS K25 AG037596NIA NIH HHS K25AG037596NIGMS NIH HHS GM101958NIGMS NIH HHS GM44664NIGMS NIH HHS GM45744NIGMS NIH HHS R01 GM044664NIGMS NIH HHS R01 GM045744NIGMS NIH HHS R01 GM084947NIGMS NIH HHS R01-GM084947NIGMS NIH HHS R01 GM101958NIGMS NIH HHS R37 GM044664NIGMS NIH HHS R37 GM045744NIH HHS DP2 OD007447NIH HHS DP2OD007447
6 · The paper itself

Abstract

X-chromosome dosage compensation by the MSL (male-specific lethal) complex is required in Drosophila melanogaster to increase gene expression from the single male X to equal that of both female X chromosomes. Instead of focusing solely on protein complexes released from DNA, here we used chromatin-interacting protein MS (ChIP-MS) to identify MSL interactions on cross-linked chromatin. We identified MSL-enriched histone modifications, including histone H4 Lys16 acetylation and histone H3 Lys36 methylation, and CG4747, a putative Lys36-trimethylated histone H3 (H3K36me3)-binding protein. CG4747 is associated with the bodies of active genes, coincident with H3K36me3, and is mislocalized in the Set2 mutant lacking H3K36me3. CG4747 loss of function in vivo results in partial mislocalization of the MSL complex to autosomes, and RNA interference experiments confirm that CG4747 and Set2 function together to facilitate targeting of the MSL complex to active genes, validating the ChIP-MS approach.

Indexed as

AcetylationAnimalsAnimals, Genetically ModifiedBlotting, WesternChromatin ImmunoprecipitationDosage Compensation, GeneticDrosophila melanogasterDrosophila ProteinsFemaleHistone-Lysine N-MethyltransferaseHistonesMaleMass SpectrometryMethylationNuclear ProteinsOxidoreductasesDrosophila ProteinsHistone-Lysine N-MethyltransferaseHistonesNDF protein, DrosophilaNuclear ProteinsOxidoreductasesSet2 protein, Drosophila

Identifiers

PMID23295261
PMCPMC3674866
OpenAlexW1987528776

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.